Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Regulation01:25

Drug Regulation

3.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.3K
CNS Stimulants: Psychedelic Agents01:22

CNS Stimulants: Psychedelic Agents

994
Hallucinogens, also known as psychedelic drugs, are a class of substances known for their ability to alter perception, cognition, and emotions. Despite their profound effects on the mind, these drugs are non-addictive, setting them apart from many other abused substances. The mechanism of action of these drugs lies in their impact on the 5-HT2A receptor in the brain. Upon activation, this receptor couples to Gq-type G proteins, triggering a cascade that releases intracellular calcium. This...
994
Phase II Reactions: Methylation Reactions01:17

Phase II Reactions: Methylation Reactions

885
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
885
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

657
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
657
Regulation of Metabolism01:19

Regulation of Metabolism

12.4K
Cellular needs and conditions vary from cell to cell and change within individual cells over time. For example, the required enzymes and energetic demands of stomach cells are different from those of fat storage cells, skin cells, blood cells, and nerve cells. Furthermore, a digestive cell works much harder to process and break down nutrients during the time that closely follows a meal compared with many hours after a meal. As these cellular demands and conditions vary, so do the amounts and...
12.4K
Hallucinogens and Psychedelics01:27

Hallucinogens and Psychedelics

950
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
950

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Physician-assisted Suicide in Albania: Is It Constitutionally Protected?

Journal of law and medicine·2025
Same journal

Interprofessional Learning with Law and Medicine: "In Reality, No Profession Is an Island".

Journal of law and medicine·2025
Same journal

Nursing Management of Intoxicated Persons under Involuntary Legislation in Emergency Departments in Metropolitan Queensland, Australia; A Focused Ethnography Study.

Journal of law and medicine·2025
Same journal

Calling for Standardised Surrogacy Birth Care Policies: A Brief Report.

Journal of law and medicine·2025
Same journal

Lack of Informed Financial Consent by Health Professionals: Uncertainty & Secrecy.

Journal of law and medicine·2025
Same journal

Detangling AI Transparency in the Medical Regulation Space.

Journal of law and medicine·2025

Related Experiment Video

Updated: Apr 4, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
06:06

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

Published on: February 5, 2018

27.1K

The case for MDMA (ecstasy) regulation.

Joshua Donelly

    Journal of Law and Medicine
    |September 10, 2015
    PubMed
    Summary

    Criminalizing 3,4-methylenedioxy-N-methamphetamine (MDMA) is not justified due to its low harm profile. Regulating MDMA through legal markets, like pharmacies, could reduce societal costs and user harm.

    Area of Science:

    • Drug policy
    • Pharmacology
    • Public health

    Background:

    • Drug-related harm is a key factor in determining legal status.
    • Current prohibition of 3,4-methylenedioxy-N-methamphetamine (MDMA) is costly and increases harm.
    • Depenalisation models offer limited benefits over full decriminalisation.

    Purpose of the Study:

    • To evaluate the harm associated with MDMA (ecstasy) use.
    • To assess the efficacy of current MDMA legal frameworks.
    • To propose a regulated legal market for MDMA supply.

    Main Methods:

    • Review of available evidence on MDMA's individual and societal harm.
    • Analysis of the Australian depenalisation model for minor drug offenses.
    • Examination of the feasibility of regulated MDMA supply.

    More Related Videos

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    10.5K
    Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
    07:30

    Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

    Published on: November 21, 2012

    14.4K

    Related Experiment Videos

    Last Updated: Apr 4, 2026

    Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
    06:06

    Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones

    Published on: February 5, 2018

    27.1K
    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
    10:17

    High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry

    Published on: April 23, 2019

    10.5K
    Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
    07:30

    Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

    Published on: November 21, 2012

    14.4K

    Main Results:

    • MDMA poses a low level of harm to individual users and negligible harm to society compared to other drugs.
    • Criminalising MDMA use lacks sound justification.
    • Current prohibitionist frameworks are costly and detrimental to ecstasy users.

    Conclusions:

    • There is no rational basis for criminalising MDMA.
    • Removing minor MDMA offenses from criminal law is preferable to depenalisation.
    • Regulated legal market, such as pharmacy supply, is a viable option to reduce harm and prohibition costs associated with MDMA (ecstasy).